158 related articles for article (PubMed ID: 20352292)
21. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
[TBL] [Abstract][Full Text] [Related]
22. Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis.
Mohammed HHH; Abbas SH; Hayallah AM; Abuo-Rahma GEA; Mostafa YA
Bioorg Chem; 2021 Jan; 106():104422. PubMed ID: 33248713
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.
Brel V; Annereau JP; Vispé S; Kruczynski A; Bailly C; Guilbaud N
Biochem Pharmacol; 2011 Dec; 82(12):1843-52. PubMed ID: 21924246
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways.
Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ
Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new 4β-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents.
Wang L; Yang F; Yang X; Guan X; Hu C; Liu T; He Q; Yang B; Hu Y
Eur J Med Chem; 2011 Jan; 46(1):285-96. PubMed ID: 21145139
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.
Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S
Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802
[TBL] [Abstract][Full Text] [Related]
27. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.
Chen MC; Pan SL; Shi Q; Xiao Z; Lee KH; Li TK; Teng CM
Cancer Sci; 2012 Jan; 103(1):80-7. PubMed ID: 21920000
[TBL] [Abstract][Full Text] [Related]
28. CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro.
Cao B; Chen H; Gao Y; Niu C; Zhang Y; Li L
Int J Mol Med; 2015 Mar; 35(3):771-6. PubMed ID: 25592869
[TBL] [Abstract][Full Text] [Related]
29. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
30. New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis.
Tian QT; Ding CY; Song SS; Wang YQ; Zhang A; Miao ZH
Biochem Pharmacol; 2018 Aug; 154():255-264. PubMed ID: 29753750
[TBL] [Abstract][Full Text] [Related]
31. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
32. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
33. An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II.
Chelouah S; Monod-Wissler C; Bailly C; Barret JM; Guilbaud N; Vispé S; Käs E
PLoS One; 2011; 6(8):e23597. PubMed ID: 21853156
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
[TBL] [Abstract][Full Text] [Related]
35. Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA.
Yadav AA; Wu X; Patel D; Yalowich JC; Hasinoff BB
Bioorg Med Chem; 2014 Nov; 22(21):5935-49. PubMed ID: 25282653
[TBL] [Abstract][Full Text] [Related]
36. DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer.
Wang Y; Sun H; Xiao Z; Zhang G; Zhang D; Bao X; Li F; Wu S; Gao Y; Wei N
Cell Commun Signal; 2018 Sep; 16(1):52. PubMed ID: 30176902
[TBL] [Abstract][Full Text] [Related]
37. Discovery and Characterization of 4-Hydroxy-2-pyridone Derivative Sambutoxin as a Potent and Promising Anticancer Drug Candidate: Activity and Molecular Mechanism.
Li LN; Wang L; Cheng YN; Cao ZQ; Zhang XK; Guo XL
Mol Pharm; 2018 Nov; 15(11):4898-4911. PubMed ID: 30223653
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors.
El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Khalifa MM; Belal A; Rashed M; El-Sharkawy A; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Eissa IH
Bioorg Chem; 2020 Oct; 103():104233. PubMed ID: 32882440
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D
J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135
[TBL] [Abstract][Full Text] [Related]
40. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
